SOFIA (Bulgaria), November 29 (SeeNews) – Israeli-based generic pharmaceuticals producer Teva expects its sales in Bulgaria to rise by around 12% to 27 million levs ($18.4 million/13.8 million euro) in 2012, the general manager of the company's local unit said.